Some mice were inoculated with BP210 cells and used as a CML model induced by BCR-ABL, while others were inoculated with BP210-T315I cells and used as an imatinib-resistant CML model induced with BCR-ABLT315I. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.